Navigation Links
Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009
Date:8/12/2009

---- 2009 2008 2009 2008 ---- ---- ---- ---- Net revenues $158.7 $165.0 $496.0 $519.3 Cost of goods sold 92.7 98.6 285.9 302.8 ---- ---- ----- ----- Gross profit 66.0 66.4 210.1 216.5 Operating expenses (including separation costs) 27.3 28.4 87.8 99.2 ---- ---- ---- ---- Operating profit 38.7 38.0 122.3 117.3 Interest expense (0.3) (1.4) (1.8) (1.4) Investment income (loss) and other 1.9 4.4 4.2 3.9 --- --- --- --- Income before income taxes 40.3 41.0 124.7 119.8 Income tax expense 14.9 14.3 45.0 45.8 ---- ---- ---- ---- Net income $25.4 $26.7 $79.7 $74.0 ===== ===== ===== ===== Income per common share-basic and diluted $0.41 $0.42 $1.29 $1.18 Dividends per common share* $0.185 $0.1825 $0.555 $0.1825 Average common shares outstanding - basic and diluted 61.7 62.5 61.8 62.5 * Our first dividend as a stand-alone public company was paid June 30, 2008. Hillenbrand, Inc. Consolidated Balance Sheets (Unaudited)
'/>"/>
SOURCE Hillenbrand, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Hillenbrand Announces Third-Quarter Earnings Release Date and Conference Call
2. Hillenbrand Expects to Report Second-Quarter Net Revenue of $170.8 Million and Revises 2009 Guidance
3. Hillenbrand Board of Directors Appoints Joe Loughrey as New Director
4. Hillenbrand Announces Dividend of $0.185 Per Share
5. Hillenbrand, Inc. Announces Corrected First-Quarter Earnings Release and Conference Call Date
6. Hillenbrand, Inc. Announces First-Quarter Earnings Release Date and Conference Call
7. Hillenbrand, Inc. Appoints Jan Santerre Vice President of Lean Business
8. Hillenbrand, Inc. Increases Quarterly Dividend to $0.185 Per Share
9. Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31
10. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
11. Hillenbrand, Inc. Announces Analyst/Investor Conference in New York Dec. 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... A new $119 million industry is taking the ... redefining the way consumers get their seafood. , ... chefs on the Emerald Coast panhandle of Northwest Florida ... the promising industry of aquaculture. , The word “sustainable” ... to fully partake in the effort, especially when it ...
(Date:6/18/2013)... David Connett, DO, vice dean, medical ... the College of Osteopathic Medicine of the Pacific (COMP) ... president of the Osteopathic Medical Board of California ... Connett, a 1984 alumnus of COMP, to the OMBC ... to the position during a conference call. , In ...
(Date:6/18/2013)... 18, 2013 -- Lauren Sciences, a privately-held biotechnology ... platform technology, announced today that it was independently ... with its V-Smart Platform, and selected as a ... Group. , The report, " Early ... Emerging Companies ," features companies MCD Group independently ...
(Date:6/18/2013)... their first patients in the ROADSTER Study, a global, ... help clear blockages in carotid arteries and prevent strokes. ... the United States are diagnosed with blockages, or plaques ... can slow or even stop blood flow to the ... a "brain attack." , Current treatment options include ...
(Date:6/18/2013)... scrambling to gather data for the FDA to support ... injury in the United States. The University of Rochester ... the Journal of Neurotrauma that it might ... of one., Jeffrey J. Bazarian, M.D., M.P.H., an associate ... first to show that measuring a combination of two ...
Breaking Medicine News(10 mins):Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
... Mitt,Romney is heading back to the Granite State ... of legislation that would provide health care for,8,700 ... 25,2007] Despite recent polls showing that seven in ... health insurance to 10 million children,across the country ...
... Spending Goes to Global Health, ASPEN, Colo., ... U.S. invested $9.3 billion last year in global ... That amount,represents 8% of the $116 billion that ... in 2006., Mary Woolley, Research!America,s president, announced ...
... in the University of Iowa College of Nursing, and ... funded for a four-year $1.2 million grant to ensure ... caring for elders with mental health issues. , The ... form the Geropsychiatric Nursing Collaborative, are in the UI ...
... Oct. 4 In a departure from,current FDA ... women and women of childbearing age to increase ... a highly potent,neurotoxin and other contaminants commonly found ... women to eat more fish without,mentioning the documented ...
... meets crucial need in ... exploding ... Services, Inc,-- an online education, enrollment, and incentive support platform ... 2007.,The Fontis Health platform (http://www.fontishealth.com ) simplifies the,administration and ...
... was issued,today by the law firms Schiffrin Barroway Topaz ... Out of public health concerns and in light of ... contaminated ground beef products,SCHIFFRIN BARROWAY TOPAZ & KESSLER, LLP ... for victims of E. coli poisoning to document,their injuries ...
Cached Medicine News:Health News:DNC: Romney an (S)CHIP Off the Bush Republican Block 2Health News:DNC: Romney an (S)CHIP Off the Bush Republican Block 3Health News:U.S. Invests $9.3 Billion in Research to Improve Health Globally 2Health News:Fontis Health Launches Online HSA Support System 2Health News:Establishment of Topps Meat Recall Registry for Victims of E. Coli Poisoning 2Health News:Establishment of Topps Meat Recall Registry for Victims of E. Coli Poisoning 3
(Date:6/18/2013)... 2013  Healthgrades, the leading online resource that ... physicians and hospitals, today issued the Healthgrades ... Healthcare Decisions to Get Your Best Outcome . The ... maternity care, gynecologic surgery, as well as hospitals ... 15 of the most common hospital-based conditions and ...
(Date:6/18/2013)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the ... a general corporate update in conjunction with its 2013 Annual ... at 2:10 p.m. Pacific Time in Carlsbad, CA. ... as follows: 2:00 p.m. – 2:10 p.m. Annual Meeting of ... 2013) 2:10 p.m. – 3:15 p.m. Corporate Presentation – ...
(Date:6/17/2013)... , June 17, 2013 DNAtrix Inc., ... CEO will present clinical data on the company,s lead ... in Quebec City, Canada on ... , DNAtrix,s CEO and a leader in the field ... clinical study entitled A PHASE I TRIAL OF A ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2
... 24 The National Community Pharmacists ... Jaeger as Executive Vice President and CEO, heralding ... the association,s recent accomplishments and lead it to ... of, independent community pharmacies and the patients they ...
... N.J., Oct. 23, 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ... Food and Drug Administration (FDA) issued a Complete Response Letter ... is intended for weight management, including weight loss and maintenance ... Index, or BMI, >/= 30) or patients who are overweight ...
Cached Medicine Technology:NCPA Announces Kathleen Jaeger as CEO 2FDA Issues Complete Response Letter for Lorcaserin New Drug Application 2FDA Issues Complete Response Letter for Lorcaserin New Drug Application 3FDA Issues Complete Response Letter for Lorcaserin New Drug Application 4FDA Issues Complete Response Letter for Lorcaserin New Drug Application 5FDA Issues Complete Response Letter for Lorcaserin New Drug Application 6
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 16 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 15 mm....
Medicine Products: